DRUG: Pembrolizumab
DRUG: Aldesleukin
DRUG: Belantamab mafodotin
DRUG: Spartalizumab
DRUG: Canakinumab
DRUG: PF-07820435
BIOLOGICAL: Sasanlimab
PROCEDURE: Cytoreductive Nephrectomy
DRUG: Active Comparator
DRUG: Belzutifan
DRUG: Palbociclib
DRUG: Telavancin Injection
PROCEDURE: Abdominal Wall Transplant with another solid organ transplant
PROCEDURE: Abdominal Wall Transplant alone
DRUG: INZ-701
DRUG: TAK-500
DRUG: Pembrolizumab
DRUG: pudexacianinium chloride
BIOLOGICAL: rapcabtagene autoleucel Regimen 1
BIOLOGICAL: rapcabtagene autoleucel Regimen 2
OTHER: Standard of Care
DRUG: LNP023
DRUG: XL092
DRUG: Nivolumab
DRUG: Ipilimumab
DRUG: Nivolumab
DRUG: Nivolumab
DRUG: Nivolumab + Relatlimab
DRUG: Cabozantinib
DEVICE: Nivolumab
RADIATION: Stereotactic Radiosurgery (SRS)
BEHAVIORAL: Exercise
BEHAVIORAL: Stretching
DEVICE: Break Wave extracorporeal lithotripsy
DRUG: Selinexor
BIOLOGICAL: CNTY-101
BIOLOGICAL: IL-2
DRUG: Lymphodepleting Chemotherapy
DEVICE: Magnetic Resonance-Guided High Intensity Focused Ultrasound
DRUG: Lyso-thermosensitive Liposomal Doxorubicin
DRUG: Cabozantinib
DRUG: Everolimus
DRUG: Lenvatinib
OTHER: Questionnaire Administration
RADIATION: Stereotactic Body Radiation Therapy
DEVICE: InnAVasc arteriovenous graft surgical implant
DRUG: Semaglutide
DRUG: Placebo
DRUG: Pegloticase 8 MG/ML [Krystexxa]
DRUG: AB598
DRUG: Zimberelimab
DRUG: Carboplatin
DRUG: Pemetrexed
DRUG: Fluorouracil
DRUG: Leucovorin
DRUG: Oxaliplatin
DRUG: IL-2
DRUG: Pembrolizumab
RADIATION: Radiotherapy
DRUG: HC-7366
DRUG: Belzutifan
OTHER: Early Nephrology Consult (ENC)
OTHER: Standard of Care (SOC)
DRUG: DISC-0974
DRUG: Placebo
PROCEDURE: Dusting without Moses 2.0 Modulation
PROCEDURE: Dusting with Moses 2.0 Modulation
OTHER: Moses 2.0 Modulation
DRUG: HFB200301
DRUG: Tislelizumab
DRUG: Sasanlimab
DRUG: Palbocicilib
DEVICE: Transcutaneous electrical nerve stimulation unit (TENS)
DRUG: Baricitinib
DRUG: Placebo
DRUG: S-equol
DEVICE: Renal Denervation
DEVICE: Catheter Ablation
DRUG: VIR-2218
PROCEDURE: Ureteroscopy
BIOLOGICAL: CABA-201
COMBINATION_PRODUCT: Implantable Microdevice (IMD)
DRUG: Cabozantinib 80 MG
DRUG: Cabozantinib 40Mg Tab
DRUG: Nivolumab
BIOLOGICAL: AB-2100
DEVICE: HistoSonics Edison System
OTHER: Alert
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Enfortumab Vedotin
DRUG: Erdafitinib
OTHER: Proton beam radiation using pencil beam scanning
DRUG: Bortezomib
DRUG: Isatuximab
DRUG: Cyclophosphamide
DRUG: Dexamethasone
DRUG: Fermented Wheat Germ Extract
DRUG: 177Lu-labeled-girentuximab
DRUG: Nivolumab
DIAGNOSTIC_TEST: 89Zr-girentuximab PET/CT
DIAGNOSTIC_TEST: 177Lu whole body (WB) planar and SPECT/CT scans
DEVICE: 6Fr Percuflex ureteral stents
DEVICE: 6Fr Tria ureteral stents
DEVICE: 4.8Fr Tria ureteral stents
DEVICE: 4.8Fr Percuflex ureteral stents
DEVICE: Selective Cytopheretic Device
OTHER: Standard of Care
BIOLOGICAL: TRK-950
BIOLOGICAL: TRK-950
BIOLOGICAL: TRK-950
DRUG: Irinotecan
DRUG: Leucovorin
DRUG: 5-FU
DRUG: Gemcitabine
DRUG: Cisplatin
DRUG: Carboplatin
DRUG: Ramucirumab
DRUG: Paclitaxel
DRUG: Nivolumab
DRUG: Pembrolizumab
DRUG: Imiquimod Cream
DRUG: Bevacizumab
DRUG: PLD
DRUG: REGN5459
DRUG: REGN5458
DIETARY_SUPPLEMENT: Protein
DRUG: Zanubrutinib
DRUG: Tacrolimus
DRUG: Zanubrutinib
DRUG: M7824
DRUG: M9241
RADIATION: Stereotactic body radiation therapy (SBRT)
DRUG: Ipilimumab
DRUG: Nivolumab
DRUG: Ciforadenant
DRUG: TIN816
OTHER: Placebo
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
OTHER: Questionnaire Administration
PROCEDURE: Stereotactic Ablative Radiotherapy
PROCEDURE: Systemic Therapy
DRUG: CHS-388
DRUG: Pembrolizumab
DRUG: Toripalimab
DRUG: Rituximab Infusion
DRUG: Oral Cyclosporine
DRUG: ianalumab s.c. q4w
DRUG: ianalumab s.c. q12w
DRUG: placebo s.c.
DRUG: Ketorolac
DRUG: Anifrolumab
DRUG: Placebo
DRUG: CAR.70/IL15-transduced CB-derived NK cells
DRUG: Fludarabine phosphate
DRUG: Cyclophosphamide
DRUG: GI-101
DRUG: Pembrolizumab (KEYTRUDA®)
DRUG: Lenvatinib
RADIATION: Local Radiotherapy
DRUG: GI-101A
DRUG: Oral calcitriol with cinacalcet rescue
DRUG: IV activated vitamin D
DRUG: Retatrutide
DRUG: Placebo
DEVICE: Cryoablation Assisted Partial Nephrectomy
DRUG: Sodium bicarbonate
DRUG: Placebo
BIOLOGICAL: Nivolumab and rHuPH20
BIOLOGICAL: Nivolumab
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Bone Scan
PROCEDURE: Computed Tomography
DRUG: Ensartinib
OTHER: Laboratory Biomarker Analysis
PROCEDURE: Magnetic Resonance Imaging
OTHER: Pharmacological Study
PROCEDURE: Positron Emission Tomography
PROCEDURE: Radionuclide Imaging
PROCEDURE: X-Ray Imaging
DRUG: Semaglutide
OTHER: Placebo
BIOLOGICAL: Atezolizumab
BIOLOGICAL: Bevacizumab
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Scan
PROCEDURE: Computed Tomography
PROCEDURE: Computed Tomography with Contrast
DRUG: Erlotinib
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
DRUG: Sodium Fluoride F-18
DRUG: Cyclophosphamide 1200 mg/Kg
DRUG: Fludarabine
DRUG: Cyclophosphamide 100 mg/Kg
RADIATION: Total Body Irradiation
DRUG: ATG
DRUG: Rituximab
DRUG: Melphalan
DEVICE: CliniMACS® TCR α/β Reagent Kit and CliniMACS® CD19 System
PROCEDURE: Kidney Transplant
DRUG: Mavyret
COMBINATION_PRODUCT: Conditioning and Stem cell infusion
PROCEDURE: Trans-arterial embolization (TAE)
DRUG: Azeliragon
DRUG: Placebo
DRUG: Dapagliflozin 10mg Tab
DRUG: Placebo
PROCEDURE: Ureteral Stent
PROCEDURE: Percutaneous Nephrostomy Tube Placement
DRUG: Neoadjuvant Lenvatinib
DRUG: Neoadjuvant Pembrolizumab
PROCEDURE: Radical nephrectomy, IVC thrombectomy, retroperitoneal lymph node dissection
DRUG: Adjuvant Pembrolizumab
DRUG: Empagliflozin
DRUG: Placebo
OTHER: Muscle Therapy
BIOLOGICAL: DK210 (EGFR)
RADIATION: Radiation therapy
BIOLOGICAL: Immune checkpoint blockers
DRUG: Chemotherapy
DRUG: Continue PD-1/PD-L1 Inhibitors treatment
OTHER: Discontinue PD-1/PD-L1-1 inhibitor
DRUG: Empagliflozin
OTHER: Placebo
DRUG: Pembrolizumab infusion
DRUG: Lenvatinib tablet
DRUG: BMS-986340
DRUG: BMS-936558-01
DRUG: Docetaxel
DEVICE: Active tDCS
DEVICE: Sham tDCS
DRUG: Tacrolimus
DRUG: Envarsus XR
DRUG: Zilebesiran
DRUG: Placebo
PROCEDURE: Dusting
PROCEDURE: Basket extraction
DRUG: Prismocitrate 18
DRUG: Letermovir
BIOLOGICAL: Ipilimumab
DRUG: Valemetostat
DRUG: STK-012
DRUG: Pembrolizumab
DEVICE: Argyle Safety Fistula Cannula with Anti-Reflux Valve
GENETIC: AGAR T cells
DRUG: Sacituzumab govitecan
DRUG: Atezolizumab
DRUG: balcinrenone/dapagliflozin 15 mg/10 mg and matching placebo for dapagliflozin 10 mg
DRUG: balcinrenone/dapagliflozin 40 mg/10 mg and matching placebo for dapagliflozin 10 mg
DRUG: dapagliflozin 10 mg and matching placebo for balcinrenone/dapagliflozin
DRUG: BDC-3042
DRUG: Cemiplimab
BIOLOGICAL: MGC026 Dose Escalation
BIOLOGICAL: MGC026 Dose for Expansion
DEVICE: Niyad (nafamostat mesylate)
DEVICE: Placebo (0.9% NaCl)
BIOLOGICAL: XmAb819
PROCEDURE: Haploidentical Bone Marrow/Kidney
PROCEDURE: Dialysis
DEVICE: trascutaneous auricular vagus nerve stimulation
DEVICE: Sham device
DRUG: Obinutuzumab
BIOLOGICAL: Atacicept
OTHER: Placebo to match Atacicept
GENETIC: ALLO-316
BIOLOGICAL: ALLO-647
DRUG: Fludarabine
DRUG: Cyclophosphamide
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
DRUG: Olaparib
BIOLOGICAL: Pembrolizumab co-formulated with hyaluronidase
BIOLOGICAL: Pembrolizumab
DEVICE: EchoMark/EchoSure
PROCEDURE: Standard of Care
BIOLOGICAL: KYV-101 anti-CD19 CAR-T cell therapy
DRUG: Standard lymphodepletion regimen
DRUG: APL-101 Oral Capsules
COMBINATION_PRODUCT: Dialysis
DRUG: Ravulizumab
DRUG: Placebo
OTHER: Background Therapy
DRUG: TOUR006 - 50 MG
DRUG: TOUR006 - 25 MG
DRUG: TOUR006 - 15 MG
OTHER: Placebo
BEHAVIORAL: Combination Exercise
DRUG: FP-045
DRUG: Bulevirtide (BLV)
DRUG: Nicotinamide riboside
DRUG: Crovalimab
DRUG: Placebo
DRUG: Ravulizumab
DEVICE: Aortix System
BIOLOGICAL: Atezolizumab
DRUG: Cabozantinib S-malate
DRUG: Nab-paclitaxel
PROCEDURE: Tumor Treating Fields Therapy
BEHAVIORAL: Lifestyle Medicine Program
BEHAVIORAL: Medically Tailored Groceries
DRUG: Atrasentan
DRUG: Atrasentan
DRUG: Placebo
DRUG: Daratumumab
DRUG: Lactated Ringers Solution for Injection
DRUG: savolitinib
DRUG: durvalumab
DRUG: sunitinib
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Scan
DRUG: Cabozantinib S-malate
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
RADIATION: Radium Ra 223 Dichloride
DRUG: survodutide
DRUG: Placebo
BIOLOGICAL: Allogenic islet cells (human, U. Chicago)
PROCEDURE: Intraportal infusion of islet cells
DEVICE: Ablative local therapy
DRUG: Voxelotor
DEVICE: MOSES laser system
BIOLOGICAL: P-MUC1C-ALLO1 CAR-T cells
DRUG: Rimiducid
DRUG: Evolocumab
DRUG: Nivolumab
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: MESNA
DRUG: B7-H3 CAR T cells
BEHAVIORAL: Share plus intervention
BEHAVIORAL: Control group
BIOLOGICAL: HAV
OTHER: AVF
DRUG: NEO212 Oral Capsule
DRUG: Ipilimumab
DRUG: Pembrolizumab
DRUG: Nivolumab
DRUG: Regorafenib
DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: FOLFIRI Protocol
DRUG: Bevacizumab
DRUG: povetacicept
DRUG: povetacicept
DEVICE: catheter ablation
DEVICE: renal artery denervation
DRUG: Cyclophosphamide
BIOLOGICAL: CART-BCMA
BIOLOGICAL: huCART19
DRUG: Fludarabine
DRUG: Empagliflozin 10 MG
DRUG: CDX-585
DRUG: VX-147
DRUG: Placebo
DRUG: Vonafexor
DEVICE: LIPOSORBER® LA-15
BEHAVIORAL: SLIMM
BEHAVIORAL: Standard Resistance Training
BEHAVIORAL: Guided Resistance Training
DRUG: Placebo
DRUG: Semaglutide
DRUG: Etelcalcetide
DEVICE: CyberKnife
DRUG: Retatrutide
DRUG: Placebo
DRUG: Retatrutide
DRUG: Placebo
DRUG: PA-824
DRUG: LY4101174
DRUG: Fenofibrate
OTHER: Placebo
BIOLOGICAL: CTX131
OTHER: IBPS-Guided Ultrafiltration
DRUG: Botensilimab
DRUG: Balstilimab
DRUG: Ipilimumab
DRUG: Nivolumab
DRUG: PLN-101095
DRUG: Pembrolizumab
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Scan
PROCEDURE: Computed Tomography
DRUG: Docetaxel
DRUG: Eribulin Mesylate
DRUG: Gemcitabine Hydrochloride
PROCEDURE: Magnetic Resonance Imaging
DRUG: Paclitaxel
BIOLOGICAL: Sacituzumab Govitecan
DRUG: BI 764198
DRUG: Placebo
BEHAVIORAL: Daily caloric restriction
OTHER: Standard advice control
PROCEDURE: Bladder Transplantation
PROCEDURE: Combined Kidney and Bladder Transplantation
DRUG: Bupropion
BEHAVIORAL: Behavioral activation therapy
DRUG: Placebo
OTHER: Clinical Management
DRUG: JSP191
DEVICE: CliniMACS Prodigy System
BIOLOGICAL: Depleted Stem Cell Transplant
BIOLOGICAL: Rabbit Anti-Thymoglobulin (rATG)
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Rituximab
PROCEDURE: Discontinuation of CRRT
DRUG: Dapagliflozin 10 MG [Farxiga]
BIOLOGICAL: OMS721
BIOLOGICAL: IMPT-514
BIOLOGICAL: IMPT-514
BIOLOGICAL: IMPT-514
RADIATION: Stereotactic Body Radiotherapy
BIOLOGICAL: Ipilimumab, Nivolumab, Pembrolizumab or Atezolizumab
DRUG: Mycophenolate Mofetil
DRUG: Mycophenolate Mofetil
DRUG: KVA12123 - Dose Escalation
DRUG: KVA12123 Plus Pembrolizumab - Dose Escalation
DRUG: KVA12123 - Dose Expansion
DRUG: KVA12123 Plus Pembrolizumab - Dose Expansion
BIOLOGICAL: FB-001
BIOLOGICAL: Placebo
DRUG: migalastat HCl 150 mg
BIOLOGICAL: second generation 4-1BBζ EGFR806-EGFRt
BIOLOGICAL: second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
DEVICE: Standard of care stent placement
OTHER: No stent placement
OTHER: Surveys
DRUG: Potassium citrate
DRUG: Crystal light
DRUG: Potassium citrate + crystal light
PROCEDURE: Interstitial Radiation Therapy
DRUG: zetomipzomib
DRUG: placebo
DRUG: Cabozantinib
DRUG: Nivolumab
DRUG: Ferumoxytol
DRUG: Iron sucrose
DRUG: Cabozantinib
DRUG: Nivolumab
DRUG: Ipilimumab
DRUG: VX-407
DRUG: Placebo
DRUG: Midazolam
DEVICE: Hemodialysis twice weekly
OTHER: Hemodialysis thrice weekly
DRUG: Balcinrenone/dapagliflozin 15 mg/10 mg and matching placebo for dapagliflozin 10 mg
DRUG: Balcinrenone/dapagliflozin 40 mg/10 mg and matching placebo for dapagliflozin 10 mg
DRUG: Dapagliflozin 10 mg and matching placebo for balcinrenone/dapa gliflozin
DRUG: Lenvatinib
DRUG: Lenvatinib Mesylate
BIOLOGICAL: Pembrolizumab
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
DRUG: VS-01 on top of SOC
OTHER: SOC (Control Group)
DRUG: Pembrolizumab
DRUG: Lenvatinib
RADIATION: Low Dose Rate Brachytherapy (LDR)
DRUG: Standard-of-Care Immunotherapy
DRUG: Emraclidine
DRUG: Finerenone (BAY94-8862 ) 10 mg
DRUG: Empagliflozin
DRUG: Empagliflozin Placebo
DRUG: Finerenone (BAY94-8862 ) 20 mg
DRUG: Finerenone Placebo
DRUG: BION-1301
DRUG: Placebo
DEVICE: Proton Beam Radiation (PBRT)
DRUG: DD-4A Chemotherapy Regimen
PROCEDURE: Complete Surgical Resection
PROCEDURE: Surgical Resection
PROCEDURE: Partial Nephrectomy
BEHAVIORAL: Plant-based diet
BEHAVIORAL: Self-management of BP medications
BEHAVIORAL: Self-monitoring of home BP
DRUG: Adipose Derived Mesenchymal Stem Cells
OTHER: Dry weight target adjustment
DRUG: Anti-hypertensive medications
DRUG: Tazemetostat
DRUG: Nivolumab
DRUG: Ipilimumab
BIOLOGICAL: Renal Autologous Cell Therapy (REACT)
PROCEDURE: Sham Comparator
DRUG: YTB323
DRUG: Pembrolizumab injection
BEHAVIORAL: Daily caloric restriction
OTHER: Standard advice control
DRUG: AB521
DRUG: Cabozantinib
DRUG: Sulforaphane (Avmacol Extra Strength)
DIETARY_SUPPLEMENT: Placebo
DRUG: EffCaMgCit
OTHER: CaAcS
DRUG: Ertugliflozin
DRUG: Metolazone
DRUG: Placebo
DRUG: Cabozantinib
DRUG: Ipilimumab
DRUG: Nivolumab
DRUG: Lenvatinib
DRUG: Everolimus
DEVICE: Custom Made Fenestrated or Branched Stent Graft
DRUG: SNP-ACTH (1-39) Gel
DRUG: Rituximab
PROCEDURE: PCNL
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Scan
DRUG: Carboplatin
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Etoposide
DRUG: Ifosfamide
DRUG: Irinotecan
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
RADIATION: Radiation Therapy
PROCEDURE: Surgical Procedure
DRUG: Topotecan
PROCEDURE: Transabdominal Ultrasound
DRUG: Vincristine
PROCEDURE: X-Ray Imaging
DRUG: Pembrolizumab
RADIATION: Radiation therapy
DRUG: Polyethylene Glycol 3350
DRUG: Daratumumab
DRUG: Tobemstomig
DRUG: Tiragolumab
DRUG: Pembrolizumab
DRUG: Axitinib
DRUG: Nivolumab
DRUG: Ipilimumab
BEHAVIORAL: mHealth Messaging Intervention Group
BIOLOGICAL: Atezolizumab
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Scan
DRUG: Cabozantinib S-malate
PROCEDURE: Computed Tomography
DEVICE: Selective Cytopheretic Device
DRUG: Cyclophosphamide
BIOLOGICAL: Neoantigen Peptide Vaccine
BIOLOGICAL: Pembrolizumab
BIOLOGICAL: Sargramostim
DRUG: RO7434656
DRUG: Placebo
OTHER: Infusion of 200% maintenance fluids as balanced crystalloid IV solution
OTHER: Oral fluids; infusion of up to 110% maintenance fluids as balanced crystalloid IV solution
DRUG: KO-2806
DRUG: Cabozantinib
DRUG: Adagrasib
DRUG: Ropivacaine Continuous Infusion Catheter
DRUG: Single Dose Liposomal Bupivicaine
OTHER: Twice-weekly hemodialysis with incremental crossover to thrice-weekly schedule
OTHER: Thrice-Weekly Hemodialysis
DRUG: Bremelanotide
DRUG: RAAS inhibition therapy
DRUG: Ketorolac
DRUG: Acetaminophen
DRUG: Oxycodone
DRUG: Hydromorphone
DRUG: Ibuprofen
DRUG: SNS-101 (anti-VISTA)
DRUG: Cemiplimab
BIOLOGICAL: Renal Autologous Cell Therapy (REACT)
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Enfortumab Vedotin
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Pembrolizumab
OTHER: Questionnaire Administration
PROCEDURE: Surgical fistula creation from patient's anatomy
DEVICE: Surgical Graft implant
DRUG: canagliflozin
DRUG: Aminohippurate Sodium Inj 20%
PROCEDURE: Cardiac Catheterization
BIOLOGICAL: Stem Cell Transplantation
DRUG: IMD Preparative Regimen
DRUG: Osteopetrosis Only Preparative Regimen
DRUG: Osteopetrosis Haploidentical Only Preparative Regimen
DRUG: cALD SR-A (Standard-Risk, Regimen A)
DRUG: cALD SR-B (Standard-Risk, Regimen B)
DRUG: cALD HR-D (High-Risk, Regimen C)
DRUG: cALD HR-D (High-Risk, Regimen D)
DRUG: VIB4920
DRUG: Placebo for VIB4920
DRUG: nedosiran
DRUG: Alintegimod
DRUG: Ipilimumab
DRUG: Nivolumab
DRUG: Angiotensin II
DRUG: Saline
BIOLOGICAL: Atezolizumab
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
OTHER: Fludeoxyglucose F-18
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Tiragolumab
PROCEDURE: X-Ray Imaging
PROCEDURE: Concomitant Renal and Urinary Bladder Allograft Transplantation
DRUG: Sulforaphane
BEHAVIORAL: Mindfulness-based stress reduction (MBSR)
BEHAVIORAL: Health enhancement program (HEP)
DEVICE: Transcutaneous Vagus Nerve Stimulation (tVNS)
DEVICE: Sham-transcutaneous Vagus Nerve Stimulation (tVNS)
DRUG: Iptacopan (part 1)
DRUG: Iptacopan (part 2)
DRUG: Placebo + standard of care
DRUG: Iptacopan + placebo
DRUG: Ceralasertib
DRUG: Olaparib
DRUG: Durvalumab
OTHER: Bone Marrow Transplant
PROCEDURE: Peripheral Blood Stem Cell Collection
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Rituximab
DRUG: Siplizumab
OTHER: Diagnostic Laboratory Biomarker Analysis
BIOLOGICAL: Nivolumab
DRUG: Relatlimab
DRUG: GBT021601
DRUG: US-APR2020
DRUG: Placebo
RADIATION: Whole brain radiation
RADIATION: Stereotactic radiation (SRS)
DRUG: Ferric Citrate
DRUG: Placebo
DRUG: TBP-PI-HBr
DRUG: Imipenem-cilastatin
DRUG: Dummy Infusion
DRUG: Dummy Tablets
DRUG: HFB200603
DRUG: Tislelizumab
DRUG: LY4052031
DEVICE: SOLTIVE Thulium Fiber Laser
DEVICE: Ho:YAG Laser
DRUG: Metformin Hcl 1000Mg Tab
DRUG: Aminohippurate Sodium 20 % Injection
DRUG: Iohexol 300 Mg/mL Injectable Solution
DRUG: Placebo
DRUG: Dapagliflozin
RADIATION: Stereotactic body radiotherapy
RADIATION: Lattice Radiation Therapy
DRUG: MDNA11
DRUG: Pembrolizumab (KEYTRUDA®)
DRUG: Felzartamab
DRUG: Potassium citrate
DRUG: Placebo
DRUG: Obinutuzumab
DRUG: Placebo
DRUG: Mycophenolate Mofetil
DRUG: Acetaminophen/paracetamol
DRUG: Diphenhydramine hydrochloride (HCl)
DRUG: Methylprednisolone
DRUG: Prednisone
PROCEDURE: Biospecimen Collection
PROCEDURE: Dual X-ray Absorptiometry
DRUG: Tegavivint
PROCEDURE: X-Ray Imaging
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Aldesleukin
BIOLOGICAL: Anti-hCD70 CAR transduced PBL
DRUG: Defibrotide
DRUG: Lorundrostat 25mg+SGLT2i QD, Washout, Placebo+SGLT2i QD
DRUG: Placebo QD + SGLT2i QD, Washout, Lorundrostat 25mg+SGLT2i QD
DRUG: Jatenzo Pill
DRUG: Pembrolizumab
DRUG: Propranolol Hydrochloride
DRUG: Nivolumab
DRUG: Avelumab
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Scan
BIOLOGICAL: CBM588 Capsules
PROCEDURE: Computed Tomography
BIOLOGICAL: Ipilimumab
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Nivolumab
DRUG: Axitinib
DRUG: Pembrolizumab
DRUG: Epclusa
DRUG: Tolvaptan Suspension
DRUG: Tolvaptan Tablets
DRUG: Empagliflozin 25 mg thrice-weekly post-hemodialysis dosing
DRUG: Empagliflozin 10 mg daily dosing
DRUG: Tivozanib
DRUG: Nivolumab
DRUG: Finerenone (Kerendia, BAY94-8862)
DRUG: Placebo
DEVICE: MOSES
DRUG: Ziltivekimab B
DRUG: Ziltivekimab C
DRUG: Placebo (Ziltivekimab B)
DRUG: Placebo (Ziltivekimab C)
BIOLOGICAL: Autologous alpha-DC1/TBVA vaccine
DRUG: Cabozantinib
DRUG: Methocarbamol
DRUG: Oxybutynin
DRUG: Belatacept Injection
DRUG: Dapagliflozin
BIOLOGICAL: XmAb®808
BIOLOGICAL: Keytruda® (pembrolizumab)
BIOLOGICAL: QXL138AM Injection every 2 weeks by IV Infusion
DRUG: Evolocumab
DRUG: Statins (Cardiovascular Agents)
BIOLOGICAL: tabelecleucel
DRUG: Colchicine
DRUG: Placebo
DEVICE: Diuretic Tuner
DRUG: Zibotentan/Dapagliflozin
DRUG: Dapagliflozin
DRUG: WAL0921
DRUG: Placebo
DEVICE: Transcutaneous auricular vagus nerve stimulation
DEVICE: Sham device
DRUG: Diuretic augmentation (hydrochlorothiazide, chlorthalidone, furosemide, torsemide, or bumetanide)
BIOLOGICAL: TIN816 70 mg lyophilisate powder
OTHER: Placebo
BIOLOGICAL: KB707
DRUG: Placebo
DRUG: iptacopan
DRUG: LOXO-435
DRUG: Pembrolizumab
DRUG: INZ-701
DRUG: zanzalintinib
DRUG: AB521
BIOLOGICAL: Nivolumab
BIOLOGICAL: NM32-2668
DRUG: Sparsentan
DRUG: Sparsentan
DRUG: Sparsentan
DRUG: Eltrombopag
BIOLOGICAL: vobramitamab duocarmazine
BIOLOGICAL: lorigerlimab
DRUG: Olaparib
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
OTHER: Questionnaire Administration
RADIATION: Stereotactic Body Radiation Therapy
DRUG: Isatuximab
DRUG: Montelukast
OTHER: Placebo
DRUG: MK-8527
DEVICE: EndoAVF Creation
DRUG: Oral NKT2152
BIOLOGICAL: Avelumab
DRUG: Axitinib
DRUG: Cabozantinib
BIOLOGICAL: Ipilimumab
DRUG: Lenvatinib
BIOLOGICAL: Nivolumab
BIOLOGICAL: Pembrolizumab
RADIATION: Stereotactic Ablative Radiotherapy
BEHAVIORAL: Combined Aerobic and Resistance Exercise via videoconferencing
DRUG: EffCaMgCit
OTHER: Placebo
DRUG: Ferrous Sulfate
DRUG: Investigational Product - MIB 626
DRUG: Placebo
DRUG: 1 month Rifapentine, Isoniazid and Vitamin B6
DRUG: LNP023
DRUG: R3R01
DRUG: BT8009
DRUG: Pembrolizumab
DRUG: Spironolactone
DRUG: Chlorthalidone
DRUG: Placebo
PROCEDURE: multimodal pain management
OTHER: goal directed fluid management
OTHER: preoperative carbohydrate loading
PROCEDURE: Donor nephrectomy
PROCEDURE: regional anesthesia
DRUG: KFA115
DRUG: pembrolizumab
DRUG: EU101
DRUG: Metformin + Standard of Care
OTHER: Placebo + Standard of Care
DRUG: ferric citrate
PROCEDURE: Serial amnioinfusions with isotonic fluid
DEVICE: Spinal needle
DRUG: Isotonic fluid
DRUG: RGLS8429
DRUG: Placebo
GENETIC: CARE T cells
DRUG: Cytoxan
DRUG: Fludara
DRUG: KT-301 (formerly US-APR2020)
DRUG: ALXN2050
DRUG: Placebo
DRUG: Rituximab, Fludarabine, Cyclophosphamide, Thymic irradiation and Siplizumab
PROCEDURE: Combined bone marrow and kidney transplant
DRUG: MT-8421
DRUG: Nivolumab
DEVICE: IMST
DEVICE: Sham Training
DRUG: MDX2001
BIOLOGICAL: Atezolizumab
DRUG: Avelumab
BIOLOGICAL: Durvalumab
BIOLOGICAL: Nivolumab
BIOLOGICAL: Pembrolizumab
DRUG: Plinabulin
RADIATION: Radiation Therapy
DRUG: Imlifidase
PROCEDURE: Plasma exchange (PLEX)
DRUG: Cyclophosphamide (CYC)
DRUG: Glucocorticoids
DRUG: Cagrilintide
DRUG: Semaglutide
DRUG: Placebo
DRUG: Tirzepatide
DRUG: Placebo
DRUG: IMSA101
DRUG: Immune checkpoint inhibitor
RADIATION: PULSAR
DRUG: Memantine
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
RADIATION: Stereotactic Radiosurgery
RADIATION: Whole-Brain Radiotherapy
DEVICE: vacuum assisted sheath
DEVICE: passive suction via conventional sheath
DRUG: Nivolumab
DRUG: Ipilimumab
DRUG: Cabozantinib
DRUG: Obinutuzumab
DRUG: MMF
DRUG: Prednisone
DRUG: Methylprednisolone
DRUG: Acetaminophen/ Paracetamol
DRUG: Diphenhydramine Hydrochloride
DEVICE: LIPOSORBER® LA-15 System
DEVICE: AV graft
PROCEDURE: surgical intervention for creation of a fistula
DRUG: Calcitriol
DRUG: DS-6000a
DRUG: DS-6000a
DRUG: R2R01
DRUG: Terlipressin
DRUG: NKT2152
DRUG: palbociclib
OTHER: sasanlimab
DRUG: ONC-392
DRUG: Pembrolizumab
DRUG: Docetaxel
DRUG: INBRX-106 - Hexavalent OX40 agonist antibody
DRUG: pembrolizumab 200 mg
DRUG: pembrolizumab 400 mg
DRUG: Carboplatin AUC-5
DRUG: Carboplatin AUC-6
DRUG: Pemetrexed 500 mg/m2
DRUG: Cisplatin 75mg/m2
DRUG: Paclitaxel 200mg/m2
DRUG: Nab paclitaxel 100mg/m2
BEHAVIORAL: Home-based walking exercise
OTHER: Attention control
DRUG: Busulfan
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: rabbit ATG
DRUG: G-CSF
BIOLOGICAL: Peripheral blood stem cell
DRUG: Empagliflozin 10 MG
DRUG: Placebo
DRUG: NBTXR3
RADIATION: SABR
DRUG: Nivolumab
DRUG: Pembrolizumab
DRUG: Cyclophosphamide
DRUG: Bortezomib
DRUG: Dexamethasone
DRUG: Daratumumab
DRUG: MAP-Target Algorithm
DRUG: Pentoxifylline
DRUG: Placebo
DRUG: Vorinostat
DRUG: IL-2 and Nivolumab
DRUG: Iptacopan
DRUG: Tolvaptan (OPC-41061)
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
BIOLOGICAL: Ipilimumab
PROCEDURE: Kidney Biopsy
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Nivolumab
DRUG: Prednisone
DRUG: Sirolimus
DRUG: PRO1160
DRUG: Cephalexin
DRUG: Cephalexin or placebo
DRUG: XL092
DRUG: Nivolumab
DRUG: Sunitinib Malate
BIOLOGICAL: AB248
BIOLOGICAL: pembrolizumab
DRUG: DCR-PHXC
DRUG: NGM831
DRUG: NGM831 plus pembrolizumab (KEYTRUDA®)
DRUG: NGM831 and NGM438 plus pembrolizumab (KEYTRUDA®)
BIOLOGICAL: V940
BIOLOGICAL: Pembrolizumab
BIOLOGICAL: Placebo
DRUG: Renin-Angiotensin (RAAS) alone
DRUG: Renin-Angiotensin (RAAS) blockers in combination with Spironolactone
DRUG: Paricalcitol
DEVICE: SelfWrap Bioabsorbable Perivascular Wrap
PROCEDURE: Untreated AVF Control
DRUG: Selenomethionine (SLM)
DRUG: Axitinib
DRUG: Pembrolizumab
BIOLOGICAL: QEQ278
BIOLOGICAL: Anti-BK polyomavirus (AntiBKV)
GENETIC: CATCH T cells
DRUG: Finerenone
OTHER: Placebo
DRUG: Cabozantinib
BIOLOGICAL: Ipilimumab
BIOLOGICAL: Nivolumab
PROCEDURE: Bone Scan
DRUG: Cabozantinib S-malate
PROCEDURE: Computed Tomography
BIOLOGICAL: Ipilimumab
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Nivolumab
PROCEDURE: Positron Emission Tomography
DRUG: INZ-701
DRUG: Control Arm (Conventional Therapy)
DRUG: 5mg Oxycodone, Q6 PRN
DRUG: 10mg Ketorolac, Q6 PRN
DRUG: Crovalimab
DRUG: NKX019
DRUG: Cyclophosphamide
DRUG: Cabozantinib
DRUG: Nivolumab
PROCEDURE: Cytoreductive nephrectomy
DRUG: Voclosporin
DRUG: Placebo Oral Capsule
DRUG: Metoprolol Succinate
DRUG: Carvedilol
DRUG: REGN5678
DRUG: Cemiplimab
DRUG: AB-101
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Rituximab
DRUG: Obinutuzumab
DRUG: Baxdrostat/dapagliflozin
DRUG: Dapagliflozin in combination with placebo
DRUG: Mezigdomide
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Scan
PROCEDURE: Computed Tomography
BIOLOGICAL: Ipilimumab
PROCEDURE: Magnetic Resonance Imaging
DRUG: Myrciaria dubia Prebiotic Supplement
BIOLOGICAL: Nivolumab
DRUG: Ravulizumab
DRUG: Placebo
Get the latest thought leadership on your Extranodal Natural Killer delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.